Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 3
1962 1
1963 1
1976 1
1983 3
1985 3
1986 1
1987 3
1988 2
1990 2
1991 1
1992 3
1993 3
1994 2
1996 1
1997 2
1998 2
1999 4
2000 1
2001 1
2002 3
2003 6
2004 1
2005 3
2006 2
2007 1
2008 2
2009 8
2010 7
2011 6
2012 4
2013 4
2014 6
2015 10
2016 6
2017 5
2018 8
2019 5
2020 15
2021 12
2022 14
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
A new approach for deducing rms proton radii from charge-changing reactions of neutron-rich nuclei and the reaction-target dependence.
Zhang J, Sun B, Tanihata I, Kanungo R, Scheidenberger C, Terashima S, Wang F, Ameil F, Atkinson J, Ayyad Y, Bagchi S, Cortina-Gil D, Dillmann I, Estradé A, Evdokimov A, Farinon F, Geissel H, Guastalla G, Janik R, Kaur S, Knöbel R, Kurcewicz J, Litvinov Y, Marta M, Mostazo M, Mukha I, Nociforo C, Ong HJ, Pietri S, Prochazka A, Sitar B, Strmen P, Takechi M, Tanaka J, Vargas J, Weick H, Winfield JS. Zhang J, et al. Among authors: marta m. Sci Bull (Beijing). 2024 Mar 26:S2095-9273(24)00207-X. doi: 10.1016/j.scib.2024.03.051. Online ahead of print. Sci Bull (Beijing). 2024. PMID: 38644131
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Stewart TG, Rebolledo PA, Mourad A, Lindsell CJ, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Bramante CT, Lenert LA, Lim S, Williamson JC, Cardona OQ, Scott J, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Rothman RL, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Stewart TG, et al. JAMA. 2023 Dec 26;330(24):2354-2363. doi: 10.1001/jama.2023.23363. JAMA. 2023. PMID: 37976072
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.
Allen-Philbey K, De Trane S, MacDougall A, Adams A, Bianchi L, Campion T, Giovannoni G, Gnanapavan S, Holden DW, Marta M, Mathews J, Turner BP, Baker D, Schmierer K. Allen-Philbey K, et al. Among authors: marta m. Ther Adv Neurol Disord. 2023 Nov 10;16:17562864231200627. doi: 10.1177/17562864231200627. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37954917 Free PMC article.
Anaesthetic management of people with multiple sclerosis.
Dubuisson N, de Maere d'Aertrijcke O, Marta M, Gnanapavan S, Turner B, Baker D, Schmierer K, Giovannoni G, Verma V, Docquier MA. Dubuisson N, et al. Among authors: marta m. Mult Scler Relat Disord. 2023 Dec;80:105045. doi: 10.1016/j.msard.2023.105045. Epub 2023 Oct 11. Mult Scler Relat Disord. 2023. PMID: 37866022 Free article. Review.
177 results